STAT+: Alnylam defends heart disease drugs after failure of AstraZeneca’s Wainua

The story
An AstraZeneca heart disease trial failure has put Alnylam under pressure. It's mounting a defense of its medicines.
How other outlets covered this
Compare allAlto found this story at 2 outlets. Same event, different framing — compare the headlines.
How this story developed
Full timelineAlto has tracked this across 2 days of coverage from 2 outlets.
- STAT+: Alnylam defends heart disease drugs after failure of AstraZeneca’s WainuaYou are here
Powered by Gab AI
The Story At A Glance
Reading this article now — analysis appears below
💡 AI analysis provides alternative perspectives on current events